Sophia Genetics SA

NASDAQ SOPH

Data sourced from

and

Daily

Download Data

Sophia Genetics SA Price to Earnings Ratio (P/E) on June 03, 2024: -10.30

Sophia Genetics SA Price to Earnings Ratio (P/E) is -10.30 on June 03, 2024, a -219.79% change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.

Sophia Genetics SA 52-week high Price to Earnings Ratio (P/E) is -1.85 on August 17, 2023, which is 82.02% above the current Price to Earnings Ratio (P/E).
Sophia Genetics SA 52-week low Price to Earnings Ratio (P/E) is -10.30 on June 03, 2024, which is 0.00% below the current Price to Earnings Ratio (P/E).
Sophia Genetics SA average Price to Earnings Ratio (P/E) for the last 52 weeks is -4.39.

NASDAQ: SOPH

Sophia Genetics SA

CEO	Dr. Jurgi Camblong M.B.A., Ph.D.
IPO Date	July 23, 2021
Location	Switzerland
Headquarters	Rue du Centre 172, Saint-Sulpice, Switzerland, 1025
Employees	430
Sector	Healthcare
Industry	Health information services

Description

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. The company offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Rolle, Switzerland.

Key trends